Primary care of patients with renal transplants

Medical Clinics of North America

Volumn 81, Issue 3, 1997, Pages 767-784

  Peddi, V R ^a   First, M R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; CADAVER DONOR; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER DISEASE; MUSCULOSKELETAL DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECIPIENT; REVIEW; SURVIVAL RATE; VASCULAR DISEASE;

EID: 0030965931     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70545-9     Document Type: Article

References (41)

1. G. Benoit C. Hiesse P. Icard Treatment of renal artery stenosis after renal transplantation Transplant Proc 19 1987 3600
2. A.E. Bittar P.J. Ratcliffe A.J. Richardson The prevalence of hyperlipidemia in renal transplant recipients: Associations with immunosuppressive and antihypertensive therapy Transplantation 50 1990 987
3. W.E. Braun Long-term complications of renal transplantation Kidney Int 37 1990 1363
4. J.M. Cecka P.I. Terasaki The UNOS Scientific Renal Transplant Registry P.I. Terasaki J.M. Cecka Clinical Transplants 1995 1996 UCLA Tissue Typing Laboratory Los Angeles 1
5. J.R. Chapman R. Mareen M. Arias Hypertension after renal transplantation: A comparison of cyclosporine and conventional immunosuppression Transplantation 43 1987 860
6. D.J. Cohen A.I. Benvenisty J. Cianci OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function Am J Kidney Dis 14 suppl 2 1989 19
7. J.J. Curtis R.G. Luke J.D. Whelchel Inhibition of angiotensin-converting enzyme in renal transplant recipients with hypertension N Engl J Med 308 1983 377
8. I. Dawidson P. Rooth W.R. Fry Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil Transplantation 48 1989 575
9. M.R. First Clinical diagnosis of renal allograft rejection K. Solez L.C. Racusen M.E. Billingham Solid Organ Transplant Rejection, Mechanisms, Pathology and Diagnosis 1996 Marcel Dekker New York 431
10. M.R. First Long-term complications after transplantation Am J Kidney Dis 22 1993 477
11. M.R. First Pretransplantation evaluation and preparation of donors and recipients H.R. Jacobson G.F. Striker S. Klahr The Principles and Practice of Nephrology 1995 Mosby Philadelphia 805
12. M.R. First J.F. Neylan L.L. Rocher Hypertension after renal transplantation J Am Soc Nephrol 4 1994 S30
13. B. Frisk H. Persson N. Wedel Study of 172 patients at 10 to 21 years after transplantation Transplant Proc 19 1987 3769
14. I.P. Gueco D.B. Evans R.Y. Calne Prolonged survival after renal transplantation: A study of 54 patients who lived ten or more years after operation with functioning allografts Transplant Proc 17 1985 108
15. W.N. Katkov R.H. Rubin Liver disease in the organ transplant recipient: Etiology, clinical impact and clinical management Transplant Rev 5 1991 200
16. H. Koyama J.M. Cecka Rejection episodes P.I. Terasaki J.M. Cecka Clinical Transplants 1992 1993 UCLA Tissue Typing Laboratory Los Angeles 391
17. H.M. Lee N. Kenyon G. Mendez-Picon Long-term survivors of kidney transplantation, mortality, rehabilitation, and immunologic reactivities Transplant Proc 19 1987 2120
18. R.G. Luke Hypertension in renal transplant recipients Kidney Int 31 1987 1024
19. M.C. Mahoney J.M. Racadio G.L. Merhar Safety and efficacy of kidney transplant biopsy: Tru-cut vs sonographically guided biopsy gun AJR Am J Roentgenol 160 1993 325
20. J.F. Mahony E. Savdie R.J. Caterson The natural history of cadaveric renal allografts beyond ten years Transplant Proc 18 1986 135
21. M.S. Markell E.A. Friedman Hyperlipidemia after organ transplantation Am J Med 87 1989 61
22. P.G. McNally J. Walls J. Feehally The effect of nifedipine on renal function in normotensive cyclosporin-A treated renal allograft recipients Nephrol Dial Transplant 5 1990 962
23. A.C. Novick H.H. Hsieh D. Steinmuller Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation: Results of a randomized prospective study Transplantation 42 1986 154
24. 1 analog misoprostol on cyclosporine nephrotoxicity Transplantation 45 1988 1126
25. I. Penn Cancers complicating organ transplantation N Engl J Med 232 1990 1767
26. I. Penn Tumors in the transplant patient H.R. Jacobson G.F. Striker S. Klahr The Principles and Practice of Nephrology 1995 Mosby Philadelphia 833
27. K.V. Rao Late complications after renal transplantation H.R. Jacobson G.F. Striker S. Klahr The Principles and Practice of Nephrology 1995 Mosby Philadelphia 844
28. K.V. Rao R.C. Andersen Long-term results and complications in renal transplant recipients: Observations in the second decade Transplantation 45 1988 45
29. K.V. Rao R.C. Andersen M.J. Lacombe Experience with renal transplantation in the second and third decades at the Hennepin County Medical Center P.I. Terasaki Clinical Transplants 1990 1991 UCLA Tissue Typing Laboratory Los Angeles
30. S.J. Rossi T.J. Schroeder S. Hariharan Prevention and management of the adverse effects associated with immunosuppressive therapy Drug Safety 9 1993 104
31. F. Sanfilippo W.K. Vaughn E.K. Spees The detrimental effects of delayed graft function in cadaver donor renal transplantation Transplantation 38 1984 643
32. Schroeder TJ, First MR, Michael AT, et al: OKT3 monoclonal antibody as a first line agent in acute renal allograft rejection [abstr]. In Program and Abstracts of the 11th Annual Meeting of the American Society of Transplant Physicians, 1992, p 281
33. K. Solez R.A. Axelsen H. Benediktsson International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kidney Int 44 1993 411
34. N.B. Sumrani V. Delaney Z. Ding Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors Transplantation 51 1991 343
35. P.I. Terasaki M. Cecka D.W. Gjertson High survival rates of kidney transplants from spousal and living unrelated donors N Engl J Med 333 1995 333
36. R.J. Tesi K. Waller C.J. Morgan Transmission of hepatitis C by kidney transplantation—the risks Transplantation 57 1994 826
37. The U.S. Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110
38. N.E. Tolkoff-Rubin R.H. Rubin Infection in the renal transplant patient H.R. Jacobson G.F. Striker S. Klahr The Principles and Practice of Nephrology 1995 Mosby Philadelphia 826
39. United Network of Organ Sharing 1995 Annual Report of The U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplant Network 1995 U.S. Department of Health and Human Services Washington, DC
40. United Network of Organ Sharing News Report, Facts and Statistics 1996 U.S. Department of Health and Human Services Washington, DC
41. United States Renal Data System USRDS 1996 Annual Data Report 1996 National Institute of Health, National Institute of Diabetes and Kidney Diseases Bethesda, MD and Am J Kidney Dis 28(suppl 2), 1996